225 related articles for article (PubMed ID: 234380)
1. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
Lawson DM; Gala RR
Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
[TBL] [Abstract][Full Text] [Related]
2. The influence of cholinergic, adrenergic, and serotonergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats.
Subramanian MG; Gala RR
Endocrinology; 1976 Apr; 98(4):842-8. PubMed ID: 1278094
[TBL] [Abstract][Full Text] [Related]
3. Restraint stress decreases afternoon plasma prolactin levels in female rats. Influence of neural antagonists and agonists on restraint-induced changes in plasma prolactin and corticosterone.
Gala RR; Haisenleder DJ
Neuroendocrinology; 1986; 43(2):115-23. PubMed ID: 3724981
[TBL] [Abstract][Full Text] [Related]
4. The interaction of dopaminergic and serotonergic drugs on plasma prolactin in ovariectomized, estrogen-treated rats.
Lawson DM; Gala RR
Endocrinology; 1976 Jan; 98(1):42-7. PubMed ID: 1248448
[TBL] [Abstract][Full Text] [Related]
5. Effect of adrenergic blocking drugs on secretion of luteinizing hormone in the ovariectomized ewe.
Jackson GL
Biol Reprod; 1977 May; 16(4):543-8. PubMed ID: 15666
[TBL] [Abstract][Full Text] [Related]
6. Further studies on the effects of adrenergic, serotonergic and cholinergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats.
Subramanian MG; Gala RR
Neuroendocrinology; 1976; 22(3):240-9. PubMed ID: 1028955
[TBL] [Abstract][Full Text] [Related]
7. Separate neural systems mediate the steroid-dependent and steroid-independent suppression of tonic luteinizing hormone secretion in the anestrous ewe.
Meyer SL; Goodman RL
Biol Reprod; 1986 Oct; 35(3):562-71. PubMed ID: 2878692
[TBL] [Abstract][Full Text] [Related]
8. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
[TBL] [Abstract][Full Text] [Related]
9. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
10. Effect of adrenergic blockade on gastric secretion altered by catecholamines in rats.
Hano J; Bugajski J; Danek L
Arch Immunol Ther Exp (Warsz); 1976; 24(4):507-24. PubMed ID: 11761
[TBL] [Abstract][Full Text] [Related]
11. Adrenergic and serotoninergic control of growth hormone secretion in adult male rats.
Collu R; Fraschini F; Visconti P; Martini L
Endocrinology; 1972 May; 90(5):1231-7. PubMed ID: 4401150
[No Abstract] [Full Text] [Related]
12. Inhibition of estrogen-induced elevation of cyclic 3',5'-adenosine monophosphate in rat uterus. I. By beta-adrenergic receptor-blocking drugs.
Szego CM; Davis JS
Mol Pharmacol; 1969 Sep; 5(5):470-80. PubMed ID: 4390446
[No Abstract] [Full Text] [Related]
13. Effect of serotonin depletion by p-chlorophenylalanine on serum prolactin levels in estrogen-treated ovariectomized rats: insights concerning the serotoninergic, dopaminergic and opioid systems.
Mallmann ES; Ribeiro MF; Spritzer PM
Horm Metab Res; 2001 Jun; 33(6):337-42. PubMed ID: 11456281
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic and dopaminergic control of growth hormone secretion in urethan anesthetized adult male rats.
Ruch W; Marbach P; Jaton AL; Bucher B; Doepfner W
Horm Res; 1978; 9(4):208-24. PubMed ID: 669571
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of mecamylamine on the nicotine induced changes in amine levels and turnover in hypothalamic dopamine and noradrenaline nerve terminal systems and in the secretion of adenohypophyseal hormones in the castrated female rat. Evidence for involvement of cholinergic nicotine-like receptors.
Anderson K; Fuxe K; Eneroth P; Agnati LF
Acta Physiol Scand; 1984 Apr; 120(4):489-98. PubMed ID: 6148837
[TBL] [Abstract][Full Text] [Related]
16. Specificity of arecoline and apomorphine and the site of action of arecoline in inhibiting the diurnal prolactin surge.
Subramanian MG; Gala RR
Proc Soc Exp Biol Med; 1977 Jul; 155(3):353-6. PubMed ID: 560020
[No Abstract] [Full Text] [Related]
17. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
Lovinger R; Holland J; Kaplan S; Grumbach M; Boryczka AT; Shackelford R; Salmon J; Reid IA; Ganong WF
Neuroscience; 1976 Dec; 1(6):443-50. PubMed ID: 11370235
[TBL] [Abstract][Full Text] [Related]
18. The ability of pimozide to prevent inhibition by dopamine analogs of cardioaccelerator nerves in cat hearts.
Ilhan M; Long JP; Cannon JG
Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):70-80. PubMed ID: 984973
[TBL] [Abstract][Full Text] [Related]
19. Effect of blockade of dopaminergic receptors on acetylcholine (Ach)-induced alterations of plasma gonadotropin and prolactin (Prl) in conscious ovariectomized rats.
Vijayan E; McCann SM
Brain Res Bull; 1980; 5(1):23-9. PubMed ID: 6767524
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
